Klotho beta

Klotho beta

Klotho beta Molekülinformation

Molecule Name
Klotho beta
Molekülalias
betaKlotho,beta-klotho,BKL,KLB,klotho beta like,klotho beta-like protein
Drug Development Progress
Anzahl der klinischen Arzneimittel3
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Target-Alias
Klotho Beta,Klotho Beta-Like Protein,B-Klotho,Klotho Beta Like,Beta-Klotho,EC 3.2.1,BKL,BetaKlotho,KLB
Molekülhintergrund
KLB (Klotho Beta) is a Protein Coding gene. Among its related pathways are RET signaling and HIV Life Cycle. GO annotations related to this gene include hydrolase activity, hydrolyzing O-glycosyl compounds and fibroblast growth factor binding. An important paralog of this gene is KL. Klotho Beta is a regulator in multiple metabolic processes, while its role in cancer remains unclear. We found the expression of βKlotho was down-regulated in human hepatocellular carcinoma tissues compared with that in paired adjacent non-tumourous liver tissues. Hepatoma cells also showed decreased expression of βKlotho compared with normal hepatocyte cells. Reintroduction of βKlotho into hepatoma cells inhibited their proliferation.

Klotho beta Produktliste

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
NGM-313NGM-313; MK-3655Phase 2 ClinicalNGM Biopharmaceuticals Inc
Hepatitis; Metabolic Dysfunction-Associated Steatotic Liver Disease; Obesity
Details
JMT-202JMT202; JMT-202Phase 2 ClinicalShanghai Jmt-Bio Inc
Hypertriglyceridemia
Details
DR-10624DR-10624; DR10624Phase 2 ClinicalZhejiang Doer Biologics Corp
Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypertriglyceridemia; Metabolic Dysfunction-Associated Steatotic Liver Disease; Metabolic Syndrome; Obesity; Overweight
Details